Estudio del polimorfismo genético de la O-demetilación del dextrometorfano (CYP2D6) en la población uruguaya

Estevez Carrizo, Francisco E; Giusti Azziz, Marcos J; Parrillo Campiglia, Susana; Prando Caballero, Miguel A.
Arch. med. interna (Montevideo) ; 17(2): 53-7, jun. 1995. ilus, tab
Artículo en Español | LILACS | ID: lil-203500

Documentos relacionados

  1. [Analysis of dextromethorphan and its metabolites in human urine by using gas chromatography-mass spectrometry].
  2. High performance liquid chromatographic determination of dextromethorphan and its metabolite in human urine.
  3. A rapid thin layer chromatographic procedure to identify poor and extensive oxidative drug metabolizers in man using dextromethorphan.
  4. Chiral analyses of dextromethorphan/levomethorphan and their metabolites in rat and human samples using LC-MS/MS.
  5. Oxidative phenotype status in related subjects.
  6. Dextromethorphan metabolism in Jordanians: dissociation of dextromethorphan O-demethylation from debrisoquine 4-hydroxylation.
  7. Polymorphism of dextromethorphan oxidation in South Indian subjects.
  8. Salivary analysis for determination of dextromethorphan metabolic phenotype.
  9. Quantitative determination of dextromethorphan and three metabolites in urine by reverse-phase high-performance liquid chromatography.
  10. Alternative methods for CYP2D6 phenotyping: comparison of dextromethorphan metabolic ratios from AUC, single point plasma, and urine.